Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.1 Early-stage (I and II) surgical intervention is the standard treatment, with adjuvant chemotherapy used to minimize the risk of recurrence in high-risk stage II cases.2 The effectiveness of chemotherapy depends on various molecular and pathological factors, underscoring the necessity for customized therapeutic approaches. Both intrinsic and extrinsic apoptosis pathways, crucial in cell death and survival, play significant roles in cancer progression and treatment resistance. Previous attempts to link single apoptosis markers with chemotherapy outcomes have yielded inconsistent results, suggesting a complex interplay of factors.3 4
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: